Search

Search results

1. Drug Coverage for low-income families: The Canadian Reality and Lessons from Switzerland and the Netherlands

   Modern medicines are essential for improving health outcomes, alleviating pain and suffering, increasing longevity, and reducing expenditures on other medical services. While there is merit to pursuing a policy that expands access to those in need, it ...

2. Bulk Purchase of Pharmaceuticals: The Experiences of the United States, Europe, and New Zealand

   Pharmaceutical costs are escalating at a rate that outpaces inflation, forcing government providers to balance consumer needs against budgetary realities. Several strategies for better managing drug expenditures are attracting significant attention, ...

3. Access to New Oncology Drugs in Canada Compared with the United States and Europe

   Cancer is the leading cause of premature death in Canada and the numbers of new cases of several major cancers have remained relatively stable. New, better treatments are needed as soon as they can be introduced. Using previously published information, ...

4. The Misguided War against Medicines 2011

   Government spending on all types of prescription drugs (patented and non-patented) is increasing faster than any other component of health spending. And new or patented medicines tend to be more expensive compared to older drugs and other health ...

5. Canada's Drug Price Paradox, 2010

   Since 2005, this study has regulary compared Canadian and American retail prices for an identical group of the 100 most commonly prescribed brand-name (mostly patented) drugs and the 100 most commonly prescribed generic drugs in Canada. This year?s study ...

6. The Misguided War Against Medicines 2010

   The Misguided War against Medicines 2010 examines all of the ways in which spending on drugs may contribute to the overall growth in total government health spending. The evidence suggests that neither patented medicines in particular, nor prescription ...

7. Average Personal Affordability of Prescription Drug Spending in Canada and the United States, 2010 edition

   The findings of this study suggest that, on average, greater government intervention in Canada?s drug markets has not provided more affordable access to prescription drugs relative to less interventionist policy in the United States. This study notes that ...

8. Fraser Forum- February 2009: Impeding Access to Prescription Drugs

   In this issue: Up Front: Public policy in tough times Veteran politician Preston Manning shares his thoughts on the economic downturn with FraserTV following a recent Fraser Institute event in Vancouver. Beware of bailout by Mark Milke Governments should ...

9. Cost Burden of Prescription Drug Spending in Canada and the United States, 2008 Edition

   There is a common misconception that American prices for prescription medications are excessive because they are often higher than prices in Canada. This leads some people to suggest that the overall cost burden of prescription drug spending in the United ...

10. Seniors and Drug Prices in Canada and the United States, 2008 Edition

    This is the Fraser Institute's third report comparing Canada-US price differences for the prescription drugs that are most important to Canadian seniors (aged 60 and older). This year's report analyzes prices for the drugs most commonly ...